Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (1060)	10/25/2001 9:04:50 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1475

They use this "v-protectant" BS to cover both molecules that are designed to specifically hit the expression of VCAM-1 and "other stuff". If this is another VCAM-1 inhibitor, then yes I have a comment.... it won't work. But that's so simple that they must again be painting a wide swath with that terminology. Haven't looked at it. Or, if I have, I don't recognize the nomenclature. One of the two scientific founders is very active at publishing, so you can scrounge around in Medline to see if you can find anything about potent immunosuppression.